Cargando…
MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue.
To determine if ovarian cancer patients would be suitable for MAGE-peptide vaccine-based immunotherapy, the frequency of expression of the MAGE-1-4 genes in ovarian tumours was assessed using reverse transcription polymerase chain reaction (RT-PCR) and product verification with digoxigenin-labelled...
Autores principales: | Gillespie, A. M., Rodgers, S., Wilson, A. P., Tidy, J., Rees, R. C., Coleman, R. E., Murray, A. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062964/ https://www.ncbi.nlm.nih.gov/pubmed/9743307 |
Ejemplares similares
-
Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines
por: Zhang, Shiqian, et al.
Publicado: (2010) -
Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases
por: Melo, Daniel Hardy, et al.
Publicado: (2017) -
Cohort study of ageing from Bagé (SIGa-Bagé), Brazil: profile and methodology
por: Thumé, Elaine, et al.
Publicado: (2021) -
Expression and Prognostic Significance of Cancer/Testis Antigens, MAGE-E1, GAGE, and SOX-6, in Glioblastoma: An Immunohistochemistry Evaluation
por: Tabatabaei Yazdi, Seyed Abbas, et al.
Publicado: (2021) -
The strain gage primer
por: Perry, Charles C, et al.
Publicado: (1955)